Emergent BioSolutions scored more than $250 million in government contract modifications for four medical countermeasures, including anthrax, smallpox and botulism vaccines.
As part of the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A direct oral penicillin challenge sufficed to remove an incorrect penicillin allergy label on people considered to have a low-risk history, the international PALACE trial
SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS